Description

MGF 2mg – Premium Mechano Growth Factor Peptide for Muscle Repair & Hypertrophy Research | Advanced IGF-1 Ec Fragment to Promote Satellite Cell Activation, Muscle Growth & Localized Recovery Insights

Unlock targeted muscle regeneration with MGF 2mg from Ion Peptide, the high-purity synthetic Mechano Growth Factor peptide designed for advanced laboratory studies on muscle hypertrophy, satellite cell activation, localized tissue repair, and post-exercise recovery. As the unique E-domain splice variant of IGF-1 (IGF-1Ec), MGF is expressed in response to mechanical stress and muscle damage, offering researchers powerful insights into rapid muscle fiber repair, new muscle cell formation, and enhanced anabolic signaling at the site of injury or training.

Premium Product Overview

MGF (Mechano Growth Factor) is supplied as a stable lyophilized acetate salt in convenient 2mg vials for easy reconstitution.

With the active C-terminal sequence Tyr-Gln-Pro-Pro-Ser-Thr-Asn-Lys-Asn-Thr-Lys-Ser-Gln-Arg-Arg-Lys-Gly-Ser-Thr-Phe-Glu-Glu-His-Lys-NH₂, molecular formula reflecting its 24-amino acid peptide structure, and molecular weight of approximately 2867 Da, MGF binds to muscle cell receptors to stimulate satellite cell proliferation and fusion with existing fibers. Manufactured at ≥99% purity (third-party HPLC & MS verified), MGF 2mg provides researchers with a precise, localized tool for investigating muscle-specific growth pathways distinct from systemic IGF-1.

Key Research Benefits of MGF 2mg

  • Localized Muscle Repair: Activates satellite cells and promotes rapid repair of damaged muscle fibers following mechanical overload or injury in research models.
  • Enhanced Muscle Hypertrophy: Supports new myofiber formation and increased muscle cross-sectional area through anabolic signaling.
  • Improved Recovery Kinetics: Accelerates post-exercise or post-injury recovery, reducing downtime and enhancing tissue remodeling.
  • Synergistic Growth Potential: Often studied alongside other GH/IGF-1 axis compounds (e.g., GHRP-2, GHRP-6, or CJC-1295) for amplified muscle-building and regenerative effects.
  • Targeted Anabolic Action: Provides site-specific effects when administered locally, making it ideal for focused muscle group research.

Researchers frequently describe MGF as the “muscle damage repair specialist” or localized growth factor for studying hypertrophy beyond traditional systemic peptides.

Incorporate these naturally for better search engine performance on pages about MGF research, Mechano Growth Factor peptides, MGF for muscle hypertrophy studies, and premium research peptides for localized repair.

Quality Assurance & Usage in Research

Sourced exclusively for laboratory research with USA-verified COAs. MGF 2mg reconstitutes easily with bacteriostatic water. Its short half-life supports localized or systemic administration protocols. Store lyophilized vials at -20°C and reconstituted solutions refrigerated.

Common Research Protocols (for reference only): Typical doses in studied models range from 100–400 mcg per injection, administered 2–3 times per week directly into the target muscle group or subcutaneously. Often used post-workout or post-injury for optimal regenerative signaling. Always follow precise reconstitution and institutional guidelines.

Important Research Considerations

MGF 2mg is a potent research chemical intended strictly for laboratory use only. Common observations include mild injection site reactions; effects are generally well-tolerated in controlled studies. It is not approved by regulatory agencies for human therapeutic, cosmetic, or performance use. Prioritize proper protocols, biomarker monitoring (e.g., muscle protein synthesis markers), and consult qualified professionals for any application beyond strict lab research.

For research purposes only. Not for human consumption, diagnostic, or therapeutic use. Always comply with local laws and institutional protocols.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “MGF 2mg”

Your email address will not be published. Required fields are marked *